Case Study



Market Opportunity


Companies with innovative products often lack resources and networks to expand globally


Our Solution


Incubated, capitalized, established and managed a global medical devices marketing and distribution company that takes exclusive licenses for such products and solutions

Performance Within Two Years


Built global distribution for 1st product, Altrazeal®, under license in over 50 countries

On March 31, 2017, Velocitas made a direct investment in ULURU Inc., the parent company of Altrazeal®, in order to further accelerate its growth and international expansion.


For more information please visit ULURU Inc.'s website at

To play, press and hold the enter key. To stop, release the enter key.